NL189856C - Zuuradditiezout van 2-amino-3-carbethoxyamino-6-(p-fluorbenzylamino)pyridine; werkwijze voor het bereiden daarvan, en farmaceutisch preparaat. - Google Patents

Zuuradditiezout van 2-amino-3-carbethoxyamino-6-(p-fluorbenzylamino)pyridine; werkwijze voor het bereiden daarvan, en farmaceutisch preparaat.

Info

Publication number
NL189856C
NL189856C NLAANVRAGE8104211,A NL8104211A NL189856C NL 189856 C NL189856 C NL 189856C NL 8104211 A NL8104211 A NL 8104211A NL 189856 C NL189856 C NL 189856C
Authority
NL
Netherlands
Prior art keywords
fluorbenzylamino
carbethoxyamino
pyridine
amino
preparing
Prior art date
Application number
NLAANVRAGE8104211,A
Other languages
English (en)
Dutch (nl)
Other versions
NL189856B (nl
NL8104211A (nl
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of NL8104211A publication Critical patent/NL8104211A/nl
Publication of NL189856B publication Critical patent/NL189856B/xx
Application granted granted Critical
Publication of NL189856C publication Critical patent/NL189856C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NLAANVRAGE8104211,A 1980-09-13 1981-09-11 Zuuradditiezout van 2-amino-3-carbethoxyamino-6-(p-fluorbenzylamino)pyridine; werkwijze voor het bereiden daarvan, en farmaceutisch preparaat. NL189856C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3034638 1980-09-13
DE3034638 1980-09-13

Publications (3)

Publication Number Publication Date
NL8104211A NL8104211A (nl) 1982-04-01
NL189856B NL189856B (nl) 1993-03-16
NL189856C true NL189856C (nl) 1993-08-16

Family

ID=6111900

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE8104211,A NL189856C (nl) 1980-09-13 1981-09-11 Zuuradditiezout van 2-amino-3-carbethoxyamino-6-(p-fluorbenzylamino)pyridine; werkwijze voor het bereiden daarvan, en farmaceutisch preparaat.

Country Status (31)

Country Link
US (1) US4481205A (xx)
JP (1) JPS5781465A (xx)
KR (1) KR860000585B1 (xx)
AR (1) AR229101A1 (xx)
AT (1) AT375924B (xx)
AU (1) AU541020B2 (xx)
BE (1) BE890331A (xx)
CA (1) CA1147736A (xx)
CH (1) CH646952A5 (xx)
CS (1) CS226037B2 (xx)
DD (1) DD201786A5 (xx)
DK (1) DK159878C (xx)
EG (1) EG15446A (xx)
ES (1) ES505423A0 (xx)
FI (1) FI79531C (xx)
FR (1) FR2490225B1 (xx)
GB (1) GB2084138B (xx)
GR (1) GR75777B (xx)
HU (1) HU182720B (xx)
IE (1) IE51547B1 (xx)
IL (1) IL63801A (xx)
IN (1) IN155674B (xx)
IT (1) IT1171520B (xx)
LU (1) LU83633A1 (xx)
NL (1) NL189856C (xx)
NO (1) NO160919C (xx)
PL (1) PL130030B1 (xx)
SE (1) SE454693B (xx)
SU (1) SU1091855A3 (xx)
YU (1) YU43037B (xx)
ZA (1) ZA816336B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416609A1 (de) * 1984-05-05 1985-11-07 Degussa Ag, 6000 Frankfurt 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten
NO860825L (no) * 1985-03-23 1986-09-24 Degussa Fremgangsmaate til fremstilling av 2-amino-3-nitro-6-(4-fluor-benzylamino)-pyridin samt 2-amino-3-karbetoksyamino-6-(4-fluor-benzylamino)-pyridin.
JPH0568848U (ja) * 1991-11-18 1993-09-17 京都機械工具株式会社 チューブ絞り器
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin
DE19625582A1 (de) * 1996-06-27 1998-01-02 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen
DE19716984A1 (de) * 1997-04-23 1998-10-29 Asta Medica Ag Verfahren zur Herstellung von reinem Flupirtin-Maleat und dessen Modifikation A
US6187324B1 (en) * 1998-08-11 2001-02-13 Kabushiki Kaisha Ogi Kogei Cosmetic composition comprising at least one of Kumazasa extract and medicinal carbon
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
US7741358B2 (en) * 2005-04-14 2010-06-22 N.V. Organon Crystal form of asenapine maleate
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
WO2009152647A1 (zh) 2008-06-20 2009-12-23 江苏恩华药业股份有限公司 芳烷基哌啶衍生物及其在制备镇痛、镇静药物中的应用
EP2361247A4 (en) * 2008-08-06 2012-08-08 Bionevia Pharmaceuticals Inc FLUPIRTINHYDROCHLORID-maleic acid co-crystal
DE102009023162B4 (de) * 2009-05-29 2011-07-07 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Flupirtin
CN102140077A (zh) * 2010-01-28 2011-08-03 范扶民 氟吡汀a晶型及其制备方法
WO2012004391A1 (en) 2010-07-09 2012-01-12 K.H.S. Pharma Holding Gmbh Process for the preparation of flupirtine maleate
CN102241626B (zh) * 2011-05-03 2013-07-03 北京华睿鼎信科技有限公司 一种马来酸氟吡汀的合成工艺
WO2013080215A1 (en) 2011-11-30 2013-06-06 Arch Pharmalabs Limited An improved process for the preparation of flupirtine and pharmaceutically acceptable salts thereof
CN103086963A (zh) * 2013-01-29 2013-05-08 吉林修正药业新药开发有限公司 一种马来酸氟吡汀a晶型化合物及中间体的合成方法
CN104086481B (zh) * 2014-07-18 2016-05-11 四川新斯顿制药股份有限公司 一种马来酸氟吡汀的合成方法
CN111100010A (zh) * 2019-12-30 2020-05-05 山东省越兴化工有限公司 一种对氟苄胺的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795858C2 (de) * 1968-07-19 1979-01-11 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Benzylaminopyridine
US3969361A (en) * 1972-05-10 1976-07-13 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler 2-Benzoyl-3-amino-pyridines

Also Published As

Publication number Publication date
KR830007556A (ko) 1983-10-21
FI79531C (fi) 1990-01-10
FI812836L (fi) 1982-03-14
AR229101A1 (es) 1983-06-15
IT1171520B (it) 1987-06-10
ZA816336B (en) 1982-09-29
YU43037B (en) 1989-02-28
FR2490225A1 (fr) 1982-03-19
FI79531B (fi) 1989-09-29
IT8149272A0 (it) 1981-09-11
SE454693B (sv) 1988-05-24
ES8206481A1 (es) 1982-08-16
IE812055L (en) 1982-03-13
EG15446A (en) 1986-06-30
DK404681A (da) 1982-03-14
SE8105425L (sv) 1982-03-14
DK159878C (da) 1991-05-13
IN155674B (xx) 1985-02-23
AT375924B (de) 1984-09-25
BE890331A (fr) 1982-03-11
GB2084138A (en) 1982-04-07
YU215781A (en) 1984-02-29
JPH0259149B2 (xx) 1990-12-11
SU1091855A3 (ru) 1984-05-07
ATA393481A (de) 1984-02-15
ES505423A0 (es) 1982-08-16
CS226037B2 (en) 1984-03-19
AU541020B2 (en) 1984-12-13
PL130030B1 (en) 1984-07-31
IL63801A (en) 1984-10-31
GB2084138B (en) 1984-07-25
DK159878B (da) 1990-12-24
IL63801A0 (en) 1981-12-31
US4481205A (en) 1984-11-06
NL189856B (nl) 1993-03-16
CA1147736A (en) 1983-06-07
HU182720B (en) 1984-03-28
CH646952A5 (de) 1984-12-28
DD201786A5 (de) 1983-08-10
KR860000585B1 (ko) 1986-05-17
NL8104211A (nl) 1982-04-01
GR75777B (xx) 1984-08-02
PL232999A1 (xx) 1982-08-16
IE51547B1 (en) 1987-01-07
LU83633A1 (de) 1982-01-21
NO160919B (no) 1989-03-06
AU7516381A (en) 1982-03-25
JPS5781465A (en) 1982-05-21
NO160919C (no) 1989-06-14
FR2490225B1 (fr) 1985-09-06
NO813082L (no) 1982-03-15

Similar Documents

Publication Publication Date Title
NL189856C (nl) Zuuradditiezout van 2-amino-3-carbethoxyamino-6-(p-fluorbenzylamino)pyridine; werkwijze voor het bereiden daarvan, en farmaceutisch preparaat.
NL188219B (nl) Camptothecinederivaten, werkwijze voor het bereiden daarvan, farmaceutische preparaten met anti-tumorwerking, werkwijze voor het bereiden daarvan.
NL188637C (nl) Werkwijze voor het continu bereiden en winnen van iso- of tereftaalzuur.
NL187349C (nl) Werkwijze voor het bereiden of vervaardigen van een farmaceutisch preparaat dat een n-aralkyl-3-fenyl-2-propeen-1-amine en/of een zuuradditiezout daarvan bevat en werkwijze voor het bereiden van deze verbindingen en de zuuradditiezouten daarvan.
NL7904059A (nl) Preparaat voor het reduceren van technetium, werkwijze voor de bereiding daarvan, en toepassingen daarvan.
NL7707936A (nl) Werkwijze voor het conserveren van basische farmaceutische preparaten.
NL7703898A (nl) Werkwijze voor het bereiden van 2-gesubstitueer- de trans-hexahydropyridoindolen, werkwijze voor het bereiden van farmaceutische preparaten met toepassing daarvan alsmede zo gevormde prepara- ten.
NL7705881A (nl) Pyridineverbindingen, werkwijze voor het berei- den van dergelijke pyridineverbindingen, werkwijze voor het bereiden van farmaceutische preparaten met dergmlijke pyridineverbindingen alsmede de gevormde preparaten.
NL193375B (nl) Werkwijze voor het bereiden van chinolinecarbonzuurderivaten.
NL7613661A (nl) Peptide-carbazaten, werkwijze voor het bereiden ervan, werkwijze voor het bereiden van farma- ceutische preparaten met toepassing daarvan alsmede zo gevormde preparaten.
NL7901241A (nl) Nieuwe gesubstitueerde 2-fenylimino-imidazolidinen, de zuuradditiezouten daarvan, farmaceutische preparaten die deze bevatten, alsmede werkwijze voor de bereiding daarvan.
NL190285C (nl) Werkwijze voor het bereiden van d,1-5-methyltetrahydrofoliumzuur; farmaceutisch preparaat.
NL7801240A (nl) Werkwijze voor het bereiden van preparaten van ioneenpolymeren, alsmede preparaten voor het sequestreren van galzuren.
NL187485C (nl) Prostaglandinederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat.
NL7705883A (nl) Pyridineverbindingen, werkwijze voor het bereiden van dergmlijke pyridineverbindingen, werkwijze voor het bereiden van farmaceutische preparaten met dergmlijke pyridineverbindingen, alsmede de aldus verkregen gevormde preparaten.
NL190485C (nl) alfa-Fluormethyl-alfa-aminoalkaanzuurderivaat, farmaceutisch preparaat dat één of meer zodanige verbindingen bevat, alsmede werkwijze voor het bereiden van de verbindingen.
NL191788C (nl) Werkwijze voor het bereiden van hydroxyfenyl alifatische zuurderivaten.
NL175524C (nl) Glycerolderivaten, deze bevattende farmaceutische preparaten, en werkwijze voor het bereiden daarvan.
NL190897C (nl) Werkwijze voor het bereiden van 17beta-hydroxy-3-oxo-17alfa-pregneen-21-carbonzuur gamma-lactonen.
NL190473C (nl) Werkwijze voor het bereiden van immunoglobulinepreparaten.
NL192457B (nl) Werkwijze voor het bereiden van dihydroxycyclobuteendion.
NL7804582A (nl) Werkwijze voor de bereiding van 2-hydroxymethyl-3-hy- droxy-6-(1-hydroxy-2-tert. butylaminoethyl) pyridine en zuuradditiezouten daarvan.
NL7803466A (nl) Cyclobutanonverbinding en werkwijze voor het bereiden daarvan alsmede voor het bereiden van cyclopropaancarbonzuurderivaten.
NL188015C (nl) Werkwijze voor het bereiden van anti-inflammatoir actieve farmaceutische preparaten.
NL7903719A (nl) Cefalosporines, werkwijze voor het bereiden daarvan en farmaceutische preparaten daaruit bereid.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
AK Correction of former applications already laid open

Free format text: SHOULD BE DELETED IN PAT.BUL. 13/83 OF 830701, PAGE 1238, COLUMN 6

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
SNR Assignments of patents or rights arising from examined patent applications

Owner name: ASTA MEDICA AKTIENGESELLSCHAFT;DEGUSSA-HUELS AKTIE

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20010911